ARSB and cardiac hypertrophy: Next, AngII induced cardiac remodeling and increased the levels of phospho-p38, phospho-JNK, and phospho-STAT3, which are important members of pathways regulating cardiac hypertrophy and apoptosis, while Arsb overexpression inhibited the increase in NMVMs (Figure 4(e)).